{
  "title": "AI In Cell and Gene Therapy Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "ai-in-cell-and-gene-therapy-market",
  "industry": "Biotechnology & Genomics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/ai-in-cell-and-gene-therapy-market",
  "scraped_at": "2026-09-17T17:45:08+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 1.38,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 3.68,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 21.61,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia-Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "Medium"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "Which region leads revenue today?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "North America leads, with 51.62% share in 2025. Its strength comes from dense sponsor presence, strong compute infrastructure, and an active FDA framework for regulated AI-related software."
      }
    },
    {
      "@type": "Question",
      "name": "Which region is expanding the fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific is the fastest-growing region, with a projected 23.62% CAGR through 2031. China, Japan, and South Korea are the key growth centers."
      }
    },
    {
      "@type": "Question",
      "name": "Why do software/AI platforms account for the largest share?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Software/AI platforms held 48.24% of revenue in 2025 because buyers value model orchestration, predictive analytics, and workflow integration more than stand-alone implementation support."
      }
    },
    {
      "@type": "Question",
      "name": "What is driving growth in AI for cell and gene therapy through 2031?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Growth is being driven by larger single-cell and multi-omic datasets, rising pharma investment in AI platforms, and wider access to GPU compute. The sector is projected to grow from USD 1.38 billion in 2026 to USD 3.68 billion by 2031 at 21.61% CAGR."
      }
    }
  ],
  "images": [
    "images/ai-in-cell-and-gene-therapy-market-size-image-1780577844153.png",
    "images/ai-in-cell-and-gene-therapy-market-1780480726202-major-players.png",
    "images/ai-in-cell-and-gene-therapy-market-AI-In-Cell-and-Gene-Therapy-Market-Market-Share-by-Component-2025-1780577652638.png",
    "images/ai-in-cell-and-gene-therapy-market-AI-In-Cell-And-Gene-Therapy-Market-Market-Share-by-Application-2025-1780480356302.png",
    "images/ai-in-cell-and-gene-therapy-market-AI-in-Cell-and-Gene-Therapy-Market-CAGR--Growth-Rate-by-Region-2026---2031-1780068216914.png",
    "images/ai-in-cell-and-gene-therapy-market-competitive-landscape-1780497762644.png",
    "images/market-snapshot.png",
    "images/pdf3.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/ai-in-cell-and-gene-therapy-market-size-image-1780577844153.png"
  ],
  "sections_count": 11
}